These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8450426)
1. Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation. Kawakami J; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T J Pharm Sci; 1993 Mar; 82(3):301-5. PubMed ID: 8450426 [TBL] [Abstract][Full Text] [Related]
2. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats. Ichikawa T; Ishida S; Sakiya Y; Sawada Y; Hanano M J Pharm Sci; 1986 Jul; 75(7):672-5. PubMed ID: 3761168 [TBL] [Abstract][Full Text] [Related]
3. Absorption and enterohepatic circulation of baicalin in rats. Xing J; Chen X; Zhong D Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266 [TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Ploeger BA; Meulenbelt J; DeJongh J Toxicol Appl Pharmacol; 2000 Feb; 162(3):177-88. PubMed ID: 10652246 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis. Takeda S; Ishthara K; Wakui Y; Amagaya S; Maruno M; Akao T; Kobashi K J Pharm Pharmacol; 1996 Sep; 48(9):902-5. PubMed ID: 8910850 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease. Wang Z; Okamoto M; Kurosaki Y; Nakayama T; Kimura T Biol Pharm Bull; 1996 Jun; 19(6):901-4. PubMed ID: 8799498 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of gastrointestinal absorption of glycyrrhizin in rats. Wang Z; Kurosaki Y; Nakayama T; Kimura T Biol Pharm Bull; 1994 Oct; 17(10):1399-403. PubMed ID: 7874064 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats. Ishida S; Sakiya Y; Ichikawa T; Awazu S Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2509-13. PubMed ID: 2605701 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method. Yamamura Y; Kawakami J; Santa T; Kotaki H; Uchino K; Sawada Y; Tanaka N; Iga T J Pharm Sci; 1992 Oct; 81(10):1042-6. PubMed ID: 1432618 [TBL] [Abstract][Full Text] [Related]
10. Glucuronide-sulfate diconjugate as a novel metabolite of glycyrrhetic acid in rat bile. Jing J; Ren W; Chen X; Wang Y; Yu Q; Wang G; Davey AK; Wang J; Jing N Drug Metab Pharmacokinet; 2008; 23(3):175-80. PubMed ID: 18574321 [TBL] [Abstract][Full Text] [Related]
11. Selective high-performance liquid chromatographic method for the determination of glycyrrhizin and glycyrrhetic acid-3-O-glucuronide in biological fluids: application of ion-pair extraction and fluorescence labelling agent. Yamamura Y; Kawakami J; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T J Chromatogr; 1991 Jun; 567(1):151-60. PubMed ID: 1918242 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model. Bredberg U; Paalzow L Pharm Res; 1990 Jan; 7(1):14-20. PubMed ID: 2300530 [TBL] [Abstract][Full Text] [Related]
13. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability. Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T Biol Pharm Bull; 1995 Feb; 18(2):337-41. PubMed ID: 7742809 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Ohtani M; Kotaki H; Uchino K; Sawada Y; Iga T Drug Metab Dispos; 1994; 22(1):2-7. PubMed ID: 8149883 [TBL] [Abstract][Full Text] [Related]
15. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. Ouellet DM; Pollack GM Drug Metab Dispos; 1995 Apr; 23(4):478-84. PubMed ID: 7600915 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic analysis of enterohepatic circulation of etodolac and effect of hepatic and renal injury on the pharmacokinetics. Ogiso T; Kitagawa T; Iwaki M; Tanino T Biol Pharm Bull; 1997 Apr; 20(4):405-10. PubMed ID: 9145219 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics of glycyrrhizin in rats. Ishida S; Sakiya Y; Ichikawa T; Taira Z Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1917-20. PubMed ID: 1394714 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of glycyrrhizin after intravenous administration to rats. Tsai TH; Liao JF; Shum AY; Chen CF J Pharm Sci; 1992 Sep; 81(9):961-3. PubMed ID: 1432649 [TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetic behavior of glycyrrhetic acid after oral administration of glycyrrhizic acid and Gancao-Fuzi-Tang. Gao QT; Chen XH; Bi KS Biol Pharm Bull; 2004 Feb; 27(2):226-8. PubMed ID: 14758039 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]